Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Wages, Salaries and Other
Ratios

Century Therapeutics (IPSC) R&D In Process (2022)

Century Therapeutics (IPSC) has disclosed R&D In Process for 1 consecutive years, with $10.0 million as the latest value for Q1 2022.

  • Quarterly R&D In Process changed N/A to $10.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2022, changed N/A year-over-year, with the annual reading at $10.0 million for FY2022, N/A changed from the prior year.
  • R&D In Process for Q1 2022 was $10.0 million at Century Therapeutics.
  • The five-year high for R&D In Process was $10.0 million in Q1 2022, with the low at $10.0 million in Q1 2022.